Data-driven design of targeted gene panels for estimating immunotherapy biomarkers

Jacob R. Bradley, Timothy I Cannings

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

We introduce a novel data-driven framework for the design of targeted gene panels for estimating exome-wide biomarkers in cancer immunotherapy. Our first goal is to develop a generative model for the profile of mutation across the exome, which allows for gene- and variant type-dependent mutation rates. Based on this model, we then propose a new procedure for estimating biomarkers such as Tumour Mutation Burden and Tumour Indel Burden. Our approach allows the practitioner to select a targeted gene panel of a prespecified size, and then construct an estimator that only depends on the selected genes. Alternatively, the practitioner may apply our method to make predictions based on an existing gene panel, or to augment a gene panel to a given size. We demonstrate the excellent performance of our proposal using an annotated mutation dataset from 1144 Non-Small Cell Lung Cancer patients.
Original languageEnglish
Article number156
JournalCommunications Biology
Publication statusPublished - 23 Feb 2022


Dive into the research topics of 'Data-driven design of targeted gene panels for estimating immunotherapy biomarkers'. Together they form a unique fingerprint.

Cite this